Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Charles S. Abrams, MD
Healthcare Provider Francis C. Wood Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
812 BRB II/III
421 Curie Blvd.
Philadelphia, Pennsylvania, United States
Dr. Abrams is Francis C. Wood Professor of medicine, pathology, and laboratory medicine, as well as director of the Blood Center for Patient Care and Discovery at the University of Pennsylvania and Children’s Hospital of Philadelphia. He is the Vice Chair for Research and Chief Scientific Officer of the Department of Medicine at the University of Pennsylvania. His clinical and research interests have focused on the role of platelets in bleeding and clotting disorders, inflammation, and metastasis formation.
Dr. Abrams is also the principal investigator of a National Institutes of Health (NIH) Program Project Grant and a K12 mentored training grant. Dr. Abrams has been elected to the American Society of Clinical Investigation and the Association of American Physicians. He was the 2016 ASH President. Dr. Abrams received his medical degree from Yale University School of Medicine. After an internship at Temple University Hospital, Dr. Abrams completed a residency and hematology-oncology fellowship at the Hospital of the University of Pennsylvania.
+myBinderRelated Content
-
Susan Paulukonis, MA, MPHSusan Paulukonis is a rare disease epide...
-
Kim Smith-Whitley, MDDr. Smith-Whitley is the director of the...
-
Webinar Series: Sickle Cell Science: Path to Progress – Bone Marrow Transplants, Other Therapies, and Sickle C...To commemorate Sickle Cell Awareness Mon...
-
Hospitalization for Acute Pain in Sickle Cell Disease: Changes in Clinical Parameters and Factors Predicting Hospita...Introduction: Acute vaso-occlusive crisi...
-
Pediatric to Adult Transition in Sickle Cell Disease: Survey Results From Young Adult PatientsBackground/Aims: We surveyed sickle cel...
-
Global Sickle Cell Disease Treatment Market 2019–2023| Evolving Opportunities with ADDMEDICA and Bristol-Myers Squ...The global sickle cell disease treatment...
-
Johns Hopkins Berman Institute of BioethicsEstablished in 1995, the Berman Institut...
